AMBERLY HOPSON: Open Payments
NPI 1073940227 · HENDERSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,030 in 55 payments from 12 companies in 2025. Trend: 2023 $79 · 2024 $765 · 2025 $1,030
Food & beverage: $930Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $360 |
| UCB, Inc. | 13 | $152 |
| Novartis Pharmaceuticals Corporation | 7 | $126 |
| GENZYME CORPORATION | 4 | $99 |
| REVANCE THERAPEUTICS, INC. | 1 | $62 |
| Amgen Inc. | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| ABBVIE INC. | 3 | $51 |
| BioWound Solutions, Inc. | 1 | $23 |
| Biofrontera Inc. | 1 | $19 |
Products named: TREMFYA, Bimzelx, DUPIXENT, COSENTYX, DAXXIFY, OTEZLA, Sotyktu, Rhapsido.
Industry payments across TX — which companies pay providers there.
